Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
批准号:
10158990
负责人:
David H Ellison
金额:
$9.35万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-02 至 2022-06-30
关键词:
AccelerationAddressAttitudeAwardBiomedical ResearchBusinessesCOVID-19COVID-19 pandemicCatalogsClinicalClinical ResearchClinical SciencesClinical TrialsClinical effectivenessCollaborationsCommunitiesCoordination and CollaborationCountryDevelopmentDiseaseEvaluationEventFosteringFundingFunding OpportunitiesFutureGoalsHealth SciencesIncidenceInformaticsInstitutesInstitutionKnowledgeLeadershipMeasurementMethodsMissionModelingOregonOutcome MeasurePanicPatient RecruitmentsProcessProtocols documentationResearchResearch DesignResearch InstituteResearch PersonnelResearch PriorityResourcesRoleScienceServicesSpeedStructureSystemTimeTrainingTranslational ResearchUniversitiesWritingclinical careimprovedinnovationinsightneglectnext generationoperationpandemic diseaseprogramsresponseskillssuccesstranslational scientist
中文摘要
俄勒冈州临床和转化研究所(OCTRI)一直在加速俄勒冈州的研究
自2006年以来,健康与科学大学。它的许多功能强大的程序帮助调查人员和学员
提供多样化的服务。在这里,我们建议OCTRI将过渡到保留我们的优势,但也
成为国家网络的一个关键枢纽,侧重于五个跨领域目标。这些与
资助机会公告的目标,以及NCATS为CTSA计划概述的目标,
一个理想的国家。该研究所的总体目标是:
总体目标1:催化临床和转化研究。
总体目标2:加强与社区的伙伴关系。
总体目标3:促进和支持科学合作。
总体目标4:扩大世纪的翻译人才队伍。
总体目标5:培养研究创新。
我们已经组织了一个高度功能化的领导结构,使我们能够实现这些目标,并将寻求
几个咨询小组的指导。我们将通过开发和支持新的信息学来促进研究
将临床护理企业与研究企业相结合,
在本地和整个CTSA网络招募患者参加临床试验。我们将致力于多样化
在转化研究过程中的利益相关者,通过与OHSU研究人员,社区
联盟和商业企业。我们将通过向学员颁发当地奖项来培养团队科学,并
新兴调查员。我们将与区域机构合作,促进社区参与的研究,
增加受训人员的多样性,并提供其他国家无法提供的生物医学研究机会。
机构职能体系我们将为下一代培养临床和转化科学家和研究人员,
注重未来研究所需的技能和态度。在所有步骤中,我们将衡量结果
在必要的时候,“转弯”
英文摘要
The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon
Health & Science University since 2006. Its many highly functional programs assist investigators and trainees
by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also
become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the
goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in
an ideal state. OCTRI's overall aims are to:
Overall Aim 1: Catalyze Clinical and Translational Research.
Overall Aim 2: Enhance Partnerships with Communities.
Overall Aim 3: Foster and Support Scientific Collaboration.
Overall Aim 4: Expand the Translational Workforce for the 21st Century.
Overall Aim 5: Cultivate Innovation in Research.
We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the
guidance of several advisory groups. We will catalyze research by developing and supporting new informatics
approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the
recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse
stakeholders in the translational research process, by partnering with OHSU investigators, community
coalitions, and business enterprises. We will foster team science through local awards to trainees and to
emerging investigators. We will partner with regional institutions to foster community-engaged research, to
enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other
institutions. We will train clinical and translational scientists and research staff for the next generation, by
focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes
and, when necessary, “turn the curve.”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
-
批准号:10158949
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10693308
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-005
-
批准号:10198074
-
项目类别:
-
资助金额:$164.5万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-004
-
批准号:10198073
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal Effects of Aldosterone
-
批准号:10266000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位:
海外基金